Trevi Therapeutics Inc
NASDAQ:TRVI

Watchlist Manager
Trevi Therapeutics Inc Logo
Trevi Therapeutics Inc
NASDAQ:TRVI
Watchlist
Price: 12.56 USD -2.03%
Market Cap: 1.6B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of TRVI.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TRVI Intrinsic Value
Not Available
Base Case Scenario
Compare TRVI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TRVI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Trevi Therapeutics Inc

Current Assets 198.3m
Cash & Short-Term Investments 194.9m
Receivables 2m
Other Current Assets 1.4m
Non-Current Assets 1.1m
PP&E 954k
Other Non-Current Assets 103k
Current Liabilities 9m
Accounts Payable 2.7m
Accrued Liabilities 6.3m
Non-Current Liabilities 527k
Other Non-Current Liabilities 527k
Efficiency

Free Cash Flow Analysis
Trevi Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Trevi Therapeutics Inc

Revenue
0 USD
Operating Expenses
-51.4m USD
Operating Income
-51.4m USD
Other Expenses
5.5m USD
Net Income
-45.9m USD
Fundamental Scores

TRVI Profitability Score
Profitability Due Diligence

Trevi Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Trevi Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

TRVI Solvency Score
Solvency Due Diligence

Trevi Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Trevi Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRVI Price Targets Summary
Trevi Therapeutics Inc

Wall Street analysts forecast TRVI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TRVI is 21.5 USD with a low forecast of 16.16 USD and a high forecast of 28.35 USD.

Lowest
Price Target
16.16 USD
29% Upside
Average
Price Target
21.5 USD
71% Upside
Highest
Price Target
28.35 USD
126% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Trevi Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TRVI is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TRVI Insider Trading
Buy and sell transactions by insiders